J&J’s Spravato first approval as monotherapy for treatment-resistant depression - The Pharma Letter

Submitted by Anonymous (not verified) on Tue, 01/21/2025 - 15:01

J&J’s Spravato first approval as monotherapy for treatment-resistant depression  The Pharma Letter